Pharma Journalist 8947 posts 0 comments

Novartis announced that the US Food and Drug Administration (FDA) accepted and granted Priority Review to capmatinib’s (INC280) New Drug Application (NDA). Capmatinib is a MET inhibitor…
Read More...

Cannabics Pharmaceuticals Inc. announced that it has signed a Memorandum Of Understanding with RCK Medical Cannabis to develop cannabis chemovars targeted to treat gastro intestinal…
Read More...

The 7th annual Pre-filled Syringes East Coast conference and exhibition is returning to Boston USA, in April. SMi Group are delighted to have Michael Song, Senior Manager, Dosage Form…
Read More...

SMi reports: Registration is now open for the Pre-Filled Syringes West Coast Conference, which will convene in London on 14th-15th June 2021. SMi Group are delighted to announce that…
Read More...

Astellas Pharma Inc. and Pfizer Inc. announced results of the final overall survival (OS) analysis from the Phase 3 PROSPER trial, which evaluated XTANDI (enzalutamide) plus androgen…
Read More...

Bayer AG announced that it entered into a definitive agreement to transfer a large part of its Berlin-based small molecule research unit to Nuvisan, an international service provider…
Read More...

Advaxis, Inc. and Personalis Inc. announced a collaboration to leverage Personalis’ ImmunoID NeXT Platform in Advaxis’ ongoing Phase 1/2 ADXS-503 (HOT Lung) program evaluating ADXS-503…
Read More...

Ligand Pharmaceuticals Incorporated announces the signing of an agreement whereby Ligand will acquire the core assets of Icagen, Inc.’s North Carolina operations, including partnered…
Read More...

LakePharma, Inc. and NJ Biopharmaceuticals LLC  announce the formation of a strategic alliance to offer streamlined antibody-drug conjugate (ADC) development solutions for the…
Read More...

ReForm Biologics LLC, a pharmaceutical technology company developing innovative platforms to improve biologic formulations and MilliporeSigma announced a global license agreement and…
Read More...